ロード中...
Clinical trial endpoints for patients with gliomas
Malignant glioma represents a diverse set of molecularly heterogeneous diseases. Few therapeutic agents have been approved despite decades of clinical trials research and pre-clinical investigation. Attempts to refine neuroimaging criteria and recent discovery of the genomic profiles linking tumor s...
保存先:
| 出版年: | Neurooncol Pract |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655446/ https://ncbi.nlm.nih.gov/pubmed/31385993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npw034 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|